Forbion raises €2.3bn, now Europe’s top biotech investor

Summary

Forbion, a venture capital firm based in Naarden, has raised €2.3 billion for two new biotech funds, marking its largest fundraising to date. This positions Forbion as Europe's largest specialist life sciences investor, with total assets of approximately €7.5 billion, and will finance around 30 companies in Europe and North America.